○ 50-GPCRs with well-defined CNS, cardiac, pulmonary and GI concerns
○ Designed to streamline the process of in vitro safety pharmacology profiling and waste less time investigating suboptimal compounds
○ Address potential toxicity early to advance the best drug candidate to market as quickly as possible
○ Available in endogenous cAMP or Calcium read-out
○ Publication-quality data in agonist and antagonist modes,
shared with control and raw data
